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cumulated medical data are needed to reduce steps by steps 
the uncertainties in the assumptions used in the present 
models. 
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Purpose or Objective: A single centre feasibility study to 
assess the reduction in sequential boost volume treated by 
rescanning patients during their final week of whole breast 
radiotherapy. 
 
Material and Methods: Patients requiring a sequential boost 
treatment who had a tumour bed seroma greater than 1cm 
on the initial radiotherapy planning (RTP) CT scan were 
considered for entry into the study.  
Thirty patients were sequentially recruited at the planning 
stage if they met this inclusion criteria. Patients were 
consented for entry into the trial and a second RTP CT scan 
(RTP 2) was conducted in their final week of whole breast 
radiotherapy. RTP 2 scan was used to determine the volume 
treated for their sequential boost.  
Both scans had the CTV outlined by the chief investigator and 
the CTV volume changes were annotated. 
 
Results: 83% of patients had a substantial reduction in CTV 
(>25%) in RTP 2 compared to RTP 1. The mean CTV reduction 
overall was 41.9% with a median reduction 42.5%. The mean 
time between scans was 27 days; median time 29 days. Mean 
time from start of whole breast radiotherapy treatment to 
RTP 2 was 14 days. 
 
Conclusion: This study shows that rescanning breast patients 
during the final week of whole breast radiotherapy leads to a 
significant decrease in treated boost volume in the majority 
of patients. 
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Purpose or Objective: Patients with spinal tumors have 
better outcomes with increased dose prescription. Due to the 
complex geometry of the treatment site and to the close 
proximity of the spinal cord, dose escalation is only possible 
with advanced techniques. This case study aims to determine 
if intensity-modulated radiation therapy (IMRT) could be a 
better option than dynamic conformal arc radiation therapy 
(DCA) for stereotactic spinal treatments. 
 
Material and Methods: Six patients previously treated with 
DCA were re-planned with IMRT. The same patient-specific 
criteria were followed in the new IMRT plan. Plan quality was 
compared by analyzing the dose-volume histogram (DVH) for 
the planning target volume (PTV) and for the spinal cord 
(SC). The conformity index (CI) and the monitor units (MU) 
number were also compared. 
 
Results: Both techniques provided adequate PTV coverage 
and SC sparing. Results favored IMRT in most of the analyzed 
PTV parameters: Dmax, D95, V95 and V100. DCA showed 
better results in PTV Dmin and D99 and had advantageous 
lower MU number. SC had superior dose sparing with IMRT 
plans. The CI was also improved by the IMRT technique. 
 
Conclusion: In general, IMRT plans proved to be a better 
planning solution, although with a significant higher number 
of MUs. IMRT treatments must be performed with higher 
accurate imaging guidance systems. 
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Purpose or Objective: To demonstrate the ability to include 
multiple lesions over the scalp, face and brain using non-
coplanar VMAT beams and a single isocentre 
73 yo man referred for post-op RT to mulitple scalp lesions, 
including bilateral spread to periauricular and parotid nodes. 
Diagnostic work up also showed an incidental right sided 
meningioma that was indicated for possible concurrent 
treatment.  
 
Material and Methods: The patient was scanned in a Klarity 
shell, on a Philips Big Bore CT. The dataset was imported into 
the TPS and diagnostic T1 and T2 MRI’s were fused for 
assisting in contouring.  
The scalp and bilateral periauricular and parotid regions were 
contoured as a single CTV and a 0.3cm PTV margin was 
added. The meningioma was contoured separately, also with 
a 0.3cm PTV margin applied.  
50.4Gy in 28 fractions was prescribed and the plan was 
generated in RayStation (v4.0.3) on an Elekta Synergy 
machine with 4° gantry spacing and a maximum delivery time 
of 90 seconds per beam. Two full transverse VMAT arcs were 
used with a partial sagittal arc added (floor at 270°). 
Isocentre placement was key due to potential collision risks. 
 
Results: Exceptional conformality was achieved. The 
introduction of the sagittal arc created a ring of dose around 
the skull providing excellent brain sparing as shown in Figure 
1. 
 
 
 
QA was perfomed using a 3D diode array with 99.6% pass rate 
at 3%/3mm criterion (6/1605 failed diodes). Absolute dose 
measurements were done using a pinpoint ionisation chamber 
inside both the scalp and meningioma PTVs indicating 
agreement with the TPS to within ±3.0%. 
XVI imaging was performed on fractions 1 to 3, then weekly, 
using grey scale match. Bony anatomy matched with <1° 
rotation. Treatment delivery averaged at 10 minutes making 
this beam arrangement extremely efficient to treat.  
Treatment was tolerated very well. Some changes to taste, 
dysphagia and mild to moderate xerostomia developed during 
the later stages of treatment. This was managed with general 
analgesia. There was no evidence of recurrence at three 
month follow up and the RO is now awaiting further 
diagnostic MRI's. 
 
Conclusion: Combining traditional transverse arcs with a 
partial non-coplanar arc is a safe and efficient technique to 
treat multiple head and neck volumes and provides 
exceptional sparing and dosimetric accuracy. The sagittal arc 
was integral to this conformal distribution over these 
complex PTV’s.  
 
 
